Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Ранг среди акций #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Цена акции
$0.117
Последняя синхронизация: 2025-04-04
Рыночная капитализация
$2.45M
Изменение (1 день)
-13.59%
Изменение (1 год)
0.00%
Страна
US
Торговля Carmell Therapeutics Corporation (CTCX)

Категория

Коэффициент P/B для Carmell Therapeutics Corporation (CTCX)
Коэффициент P/B на August 2026 TTM: -0.06
Согласно последним финансовым отчетам и цене акций Carmell Therapeutics Corporation, текущий коэффициент P/B (TTM) составляет -0.06. В конце 2023 он составлял 95.93.
История P/B для Carmell Therapeutics Corporation с 2021 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
2026 (TTM) -0.06 -99.85%
2024 -37.13 -138.70%
2023 95.93 -161.62%
2022 -155.68 -19.29%
2021 -192.90 0.00%
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -11,404.63%
US
6.2413 -11,225.31%
NL
- -
CH
- -
KR
3.4612 -6,269.70%
BE